EUCAST Technical Note on tigecycline

Saved in:
Bibliographic Details
Published inClinical microbiology and infection Vol. 12; no. 11; pp. 1147 - 1149
Main Authors Brown, D.F.J., Canton, R., MacGowan, A.P., Mouton, J.W., Rodloff, A., Goldstein, F., Odenholt, I., Steinbakk, M., Varaldo, P., Hryniewicz, W., The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee, Kahlmeter, G.
Format Journal Article
LanguageEnglish
Published Oxford, UK Elsevier Ltd 01.11.2006
Blackwell Publishing Ltd
Subjects
Anti-Bacterial Agents - pharmacokinetics
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Bacteria - classification
Bacteria - drug effects
Bacterial Infections - drug therapy
Breakpoints
Clinical Trials as Topic
EUCAST Technical Note
Humans
Microbial Sensitivity Tests
Minocycline - analogs & derivatives
Minocycline - pharmacokinetics
Minocycline - pharmacology
Minocycline - therapeutic use
Species Specificity
susceptibility testing
tigecycline
Breakpoints
susceptibility testing
EUCAST Technical Note
tigecycline
Online AccessGet full text

Cover

More Information
Bibliography:G. Kahlmeter (chairman), D. F. J. Brown (scientific secretary), R. Canton (clinical data co‐ordinator), A. P. MacGowan (BSAC, UK), J. W. Mouton (CRG, The Netherlands), A. Rodloff (DIN, Germany), F. Goldstein (CA‐SFM, France), I. Odenholt (SRGA, Sweden), M. Steinbakk (NWGA, Norway), P. Varaldo (Italy, for EUCAST General Committee), W. Hryniewicz (Poland, for EUCAST General Committee).
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Technical Report-1
ObjectType-Feature-3
content type line 23
ISSN:1198-743X
1469-0691
DOI:10.1111/j.1469-0691.2006.01578.x